Overview

Anabolic Therapy in Postmenopausal Osteoporosis

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
In this research study we want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Denosumab